Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |